It was also reported that Isoquercetin could improve the histological characteristics of OVX-induced osteoporosis by inhibiting HIF-1α and increasing β-catenin expression, which is biomarker of osteoblast differentiation [45]. This evidence concerns the gene HIF1A and osteoporosis.